Docetaxel-associated myalgia–arthralgia syndrome in patients with breast cancer

BACKGROUND: As taxanes are increasingly used in oncology, the myalgia–arthralgia syndrome (M-AS) that represents an adverse effect of these drugs is becoming more common. Nevertheless, information regarding predisposing factors, prevention, and therapy of the syndrome is still lacking. PATIENTS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Seguin, Chelsea, Kovacevich, Natalie, Voutsadakis, Ioannis A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5271389/
https://www.ncbi.nlm.nih.gov/pubmed/28176956
http://dx.doi.org/10.2147/BCTT.S124646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5271389/
https://www.ncbi.nlm.nih.gov/pubmed/28176956
http://dx.doi.org/10.2147/BCTT.S124646

Ejemplares similares